FDA builds home healthcare website:
This article was originally published in Clinica
Executive Summary
The FDA has invited manufacturers of infusion pumps to contribute instructions for use and product information to a new agency-sponsored website on devices intended for home healthcare use. The agency wants information on pumps marketed during or after 1984. The decision to consolidate such information in a central location is the result of a public meeting in June 2001 by the agency's home healthcare committee. The panel decided that promoting the safe use of infusion pumps was a significant health challenge.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.